Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1985 1
1996 1
1997 2
1998 3
1999 2
2000 2
2001 2
2003 1
2004 5
2005 7
2006 2
2007 4
2008 2
2009 7
2010 5
2011 3
2012 6
2013 3
2014 6
2015 8
2016 5
2017 5
2018 5
2019 5
2020 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29888659

88 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1.
Nishio S, Kitagawa R, Shibata T, Yoshikawa H, Konishi I, Ushijima K, Kamura T. Nishio S, et al. Cancer Chemother Pharmacol. 2016 Oct;78(4):785-90. doi: 10.1007/s00280-016-3133-4. Epub 2016 Aug 23. Cancer Chemother Pharmacol. 2016. PMID: 27553435 Clinical Trial.
Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.
Rosen VM, Guerra I, McCormack M, Nogueira-Rodrigues A, Sasse A, Munk VC, Shang A. Rosen VM, et al. Int J Gynecol Cancer. 2017 Jul;27(6):1237-1246. doi: 10.1097/IGC.0000000000001000. Int J Gynecol Cancer. 2017. PMID: 28448304 Free PMC article. Review.
88 results